Hyperbaric Oxygen Therapy: Enhancing Regeneration and Healthy Ageing

Key Takeaways

• Ageing is a complex biological process involving oxidative stress, mitochondrial dysfunction, chronic inflammation, vascular change, epigenetic alteration, cellular senescence and declining regenerative capacity. ¹
• Hyperbaric oxygen therapy combines near-pure oxygen with increased atmospheric pressure. This substantially increases dissolved oxygen in the blood and may activate pathways involved in angiogenesis, inflammation control, mitochondrial function, antioxidant defence, stem-cell mobilisation and tissue repair. ²
• Human studies suggest that HBOT may support cognitive function, cerebral blood flow, cardiorespiratory performance, insulin sensitivity, skin structure and physical resilience in selected populations. ^{3 4 5 6 7 8}
• Emerging research suggests that HBOT may improve aspects of sleep quality, particularly in people with poor sleep before treatment. The evidence is still developing and requires further controlled research. ^{9 10}
• The role of HBOT in healthy individuals has not been established. Current evidence is better understood as support for selected aspects of physiological function rather than proof of broad age reversal.
• Treatment should be based on the individual’s goals, medical history and existing health conditions. HBOT is a medical adjunct and does not replace standard medical or surgical care, rehabilitation, restorative sleep, exercise, good nutrition or other foundations of long-term health.

Quick Summary

Ageing is associated with a gradual decline in physical, cognitive, vascular, metabolic and regenerative function. These changes arise through interconnected processes that include chronic inflammation, oxidative stress, mitochondrial dysfunction, reduced angiogenesis, stem-cell exhaustion, cellular senescence and epigenetic alteration. ¹

Hyperbaric oxygen therapy, or HBOT, involves breathing near-pure oxygen inside a chamber pressurised above normal atmospheric pressure. The increased pressure allows substantially more oxygen to dissolve directly into plasma. Repeated, controlled changes between high oxygen exposure and relative reductions in oxygen concentration may also activate oxygen-sensitive signalling pathways through the hyperoxic-hypoxic paradox. ^{2 11}

Research suggests that HBOT may favourably influence several physiological systems involved in healthy ageing. Reported outcomes include changes in cerebral blood flow, cognitive performance, cardiorespiratory fitness, mitochondrial function, insulin sensitivity, skin structure and patient-reported sleep quality. The strength of evidence differs by outcome and population. ^{3 4 5 6 7 8 9 10}

HBOT should not be viewed as a shortcut or a replacement for the fundamentals of health. Where clinically appropriate, it may be integrated as a medically supervised adjunct within a wider strategy that includes preventive care, exercise, nutrition, restorative sleep, healthy body composition, stress management and psychological wellbeing.

The Biology of Ageing and Regeneration

Ageing reflects progressive changes across interconnected biological systems, including mitochondrial function, vascular health, immune regulation, cellular repair and stem-cell activity. Over time, these changes can reduce the body’s capacity to maintain homeostasis, respond to physiological stress and repair damaged tissue. ¹

Several of these processes are influenced by oxygen-dependent cellular signalling. HBOT creates a controlled physiological stimulus that may affect pathways involved in angiogenesis, inflammation, mitochondrial function, antioxidant defence, stem-cell mobilisation and cellular senescence. ²

The clinically relevant question is whether appropriately prescribed HBOT may support biological processes associated with maintaining function, recovery and physiological resilience over time.

What Is Hyperbaric Oxygen Therapy?

Patients undergoing HBOT breathe near-pure oxygen inside a chamber pressurised above normal atmospheric pressure.

At sea level, air contains approximately 21% oxygen. In protocols using near-pure oxygen at around 2 atmospheres absolute, or ATA, substantially more oxygen dissolves directly in plasma. This increases oxygen availability to tissues, including areas where delivery may be limited by inflammation, swelling or impaired microcirculation. ²

The temporary rise in tissue oxygen is only one part of treatment. HBOT also creates a controlled physiological stimulus that can influence pathways involved in tissue repair, vascular function, inflammation, cellular metabolism and regeneration.

How HBOT May Support Healthy Ageing: Key Physiological Mechanisms

Hyperoxic-Hypoxic Paradox

During protocols that use scheduled air breaks, patients temporarily remove the oxygen mask and breathe medical-grade air while remaining inside the pressurised chamber.

The rapid transition from a high-oxygen environment to a lower oxygen concentration may be interpreted at the cellular level as relative hypoxia, even though overall oxygen saturation remains high. This response is known as the hyperoxic-hypoxic paradox. ¹¹

Controlled fluctuations in oxygen exposure may activate regenerative biochemical responses, including:

• increased expression of hypoxia-inducible factor-1, or HIF-1
• increased matrix metalloproteinase activity
• increased vascular endothelial growth factor, or VEGF
• stimulation of stem-cell proliferation
• activation of pathways involved in new blood-vessel formation
• mitochondrial and antioxidant adaptation

Angiogenesis

Angiogenesis, the generation of new blood vessels, is an important mechanism through which HBOT may support healthy ageing.

Ageing is associated with reduced capillary density and angiogenic capacity. This can compromise vascular homeostasis and tissue oxygenation. HBOT may promote angiogenic signalling through pathways involving HIF-1 and nitric oxide, increasing growth factors such as VEGF, epidermal growth factor, platelet-derived growth factor, fibroblast growth factor-2 and stromal cell-derived factor-1. ^{2 11}

New vasculature may support tissue oxygenation beyond the immediate treatment period.

Anti-Inflammatory Effects

The persistent low-grade inflammatory state associated with ageing is often called inflammageing. It contributes to the development and progression of age-related disease.

Research reviewed in the HBOT literature has reported reductions in pro-inflammatory cytokines and mediators including IL-1β, IL-2, IL-6, TNF-α, IFN-γ, PGE2 and COX-2. Increases have also been reported in anti-inflammatory mediators including IL-1 receptor antagonist, IL-4 and IL-10. ²

Further research is needed to determine how these cellular and molecular findings translate into sustained clinical benefits across different ageing populations.

Stem-Cell Mobilisation and Functional Enhancement

The regenerative capacity of human tissue declines with age. Ageing affects stem-cell number, self-renewal and differentiation potential.

Hyperbaric exposure has been studied in relation to circulating stem and progenitor cells. In a study of hyperbaric air, stem progenitor cells were mobilised nearly two-fold after nine exposures and approximately three-fold 72 hours after the final exposure. ¹²

In a separate study of hyperbaric oxygen, one exposure to 2.0 ATA oxygen for two hours doubled circulating CD34-positive cells. Across 20 treatments, circulating CD34-positive cells increased approximately eight-fold. ¹³

These findings suggest that repeated hyperbaric exposure may stimulate endogenous repair systems, although clinical significance depends on the condition being treated and the wider biological context.

Antioxidant Activity and Mitochondrial Biogenesis

Like other hormetic stressors, including exercise, a single HBOT exposure can temporarily increase oxidative stress. This short-lived stimulus may activate endogenous antioxidant defence systems. ²

HBOT has also been linked to mitochondrial function and potentially to mitochondrial biogenesis through pathways involving SIRT1 and PGC-1α. During hyperoxia, changes in mitochondrial metabolism and reactive oxygen species may activate adaptive pathways involving HIF-1, NAD+, SIRT1, PGC-1α, FOXO3a and Nrf2. ²

Nrf2 regulates several downstream antioxidant targets, including:

• haem oxygenase-1
• NAD(P)H quinone dehydrogenase 1
• catalase
• glutathione peroxidase
• superoxide dismutase
• glutamate-cysteine ligase catalytic subunit

HBOT may also reduce expression of selected pro-oxidant enzymes. The aim is not to eliminate reactive oxygen species, but to stimulate a more effective adaptive antioxidant response.

Cellular Senescence and Telomere Length

A 2020 prospective study reported that, after 60 HBOT sessions over three months, telomere length in T-helper, T-cytotoxic, natural-killer and B cells increased by more than 20%. Senescent-cell proportions declined by approximately 10% to 37% across the immune-cell populations studied. ¹⁴

These findings are scientifically interesting, but they do not prove that HBOT reverses the entire ageing process or extends human lifespan. Telomere length and cellular senescence are individual components of a much broader biological system, and their long-term clinical significance remains uncertain.

Clinical Evidence for HBOT in Healthy Ageing and Regeneration

Vascular Ageing and Cognitive Function

Age-related changes in cerebral microcirculation can include increased blood-brain barrier permeability, endothelial dysfunction, inflammation, mitochondrial impairment, oxidative stress, reduced Nrf2 activity, NAD+ depletion and impaired neurovascular coupling.

A review by Balasubramanian and colleagues concluded that HBOT may influence several pathways involved in cerebrovascular ageing, including endothelial function, microvascular density, blood-brain barrier integrity, mitochondrial function, cellular metabolism, inflammation and oxidative stress. ¹⁵

In a randomised controlled trial of healthy older adults, HBOT was associated with improved cognitive performance and regional cerebral blood flow. The most prominent improvements were seen in:

• attention
• information-processing speed
• executive function

These domains commonly decline with age. ³

Cardiac Function

In a small observational study, HBOT was associated with improvements in several measures of left-ventricular systolic function and overall cardiac performance. The evidence remains limited, particularly for diastolic function and long-term clinical relevance. ¹⁶

Respiratory Capacity and Physical Performance

A randomised controlled trial in older adults reported improvements in maximal oxygen consumption and oxygen uptake at the first ventilatory threshold after HBOT. Cardiac imaging also showed increased myocardial perfusion, which may have contributed to the improvement in exercise performance. ⁴

In a separate blinded randomised trial of middle-aged athletes, HBOT was associated with improvements in maximal oxygen uptake, oxygen uptake at the first ventilatory threshold, mitochondrial respiration and mitochondrial mass. ⁵

These findings suggest that HBOT may support physical performance and mitochondrial adaptation in selected populations. Larger studies are needed to identify who is most likely to benefit and how treatment should be integrated with training.

Training remains the stimulus for adaptation. Exercise programming, restorative sleep, good nutrition, appropriate load management, physiotherapy and rehabilitation remain central. HBOT should not replace these foundations, but it may be considered as an adjunct around periods of intensive training, recovery or rehabilitation where medically appropriate. ¹⁷

Sleep Quality and Restorative Sleep

Sleep is central to healthy ageing, cognition, physical recovery, immune regulation and metabolic health. It should be considered both as a foundation of health and as a potential treatment outcome.

A 2026 retrospective longitudinal study evaluated 395 patients who completed 60 HBOT sessions at 2.0 ATA in healthy-ageing, long-COVID and post-traumatic stress disorder programmes. Patient-reported sleep quality improved across all three groups. Improvements included subjective sleep quality, time taken to fall asleep and sleep disturbances; daytime dysfunction also improved in the healthy-ageing and long-COVID groups. The greatest changes occurred in people with poor sleep at baseline. ⁹

The study did not include an untreated control group and relied on questionnaires rather than objective sleep measures. It therefore shows an association between the HBOT programme and improved sleep quality, but cannot establish that HBOT alone caused the change. ⁹

A 2024 meta-analysis included seven randomised controlled trials and 461 patients with Parkinson’s disease and sleep disorders. Adding HBOT to standard treatment was associated with improvements in sleep efficiency, total sleep time, slow-wave and REM sleep, sleep latency, awakenings, Pittsburgh Sleep Quality Index scores and daytime sleepiness. ¹⁰

All seven trials were conducted in Chinese patient populations, overall study quality was limited and safety reporting was inconsistent. The findings support further research rather than HBOT as a universal treatment for sleep disorders.

HBOT should not replace appropriate investigation or treatment for obstructive sleep apnoea, chronic insomnia, restless legs syndrome, circadian disorders, medication-related sleep disturbance or other medical and psychological causes of poor sleep.

Skin Ageing

A prospective clinical study examined skin biopsies from 13 male participants after a course of HBOT. Reported changes included:

• increased collagen density
• longer elastic fibres
• increased blood-vessel density
• reduced fibre fragmentation
• fewer senescent cells

No significant changes were observed in elastic-fibre density or thickness. The study was small and requires confirmation in larger, more diverse populations. ⁸

Insulin Resistance

Early human studies suggest that HBOT may improve insulin sensitivity. In a randomised placebo-controlled crossover trial in people with type 2 diabetes, one treatment improved tissue-specific insulin sensitivity and mitochondrial capacity in skeletal muscle, liver and white adipose tissue, alongside changes in insulin-signalling and antioxidant pathways. ⁶ A separate study found that peripheral insulin sensitivity improved after three sessions and remained higher through 30 treatments. ⁷

In a mouse model of type 2 diabetes, HBOT improved glucose tolerance and insulin sensitivity, with increased skeletal-muscle GLUT4 and AMPK activity and higher UCP1 expression in brown adipose tissue. These preclinical findings should not be assumed to translate directly to humans. ¹⁸

HBOT is not a replacement for established prevention or treatment of insulin resistance and type 2 diabetes. Nutrition, regular physical activity, healthy body composition, restorative sleep and appropriate medical management remain fundamental.

Current Medical Perspective

Hyperbaric oxygen therapy has genuine physiological and clinical potential, but healthy ageing is too complex to be reduced to a single treatment or biomarker.

Changes in telomere length, cellular senescence, inflammatory markers or mitochondrial function may provide useful biological information. They do not, on their own, prove that ageing has been reversed or that lifespan will be extended.

The studies discussed here report potential benefits across cognition, cerebral circulation, physical performance, metabolic function, skin structure and sleep. Evidence strength varies. Some studies are randomised and controlled, while others are observational, retrospective, mechanistic or based on small patient populations.

HBOT is best understood as a medical adjunct. It may support repair, adaptation and recovery, but it should be integrated into a wider care strategy and must not delay or replace medically necessary treatment.

Typical HBOT Treatment Approach for Healthy Ageing and Regeneration

There is no single HBOT protocol that is appropriate for every person or every goal.

Treatment strategy should be based on:

• the individual’s medical history
• existing diagnoses and medications
• the primary clinical or performance goal
• baseline physical, cognitive, metabolic or sleep measures

The research reviewed in this article includes courses ranging from approximately 10 to 60 sessions or exposures. Protocols differed according to whether the outcome of interest was cognition, physical performance, mitochondrial function, metabolic health, tissue repair or cellular biomarkers.

The number, pressure, duration and frequency of sessions should be determined by a medical doctor trained in hyperbaric oxygen medicine. Treatment should be purposeful, medically supervised and reviewed against clearly defined goals.

Safety and Side Effects of HBOT

HBOT is generally safe and well tolerated when it is properly prescribed and delivered in an appropriate medical setting. ²

It remains a medical treatment with contraindications, potential side effects and specific safety requirements. It may not be appropriate for people with certain pre-existing conditions.

Every patient should undergo assessment by a physician trained in hyperbaric medicine before treatment. The assessment should consider medical history, medications, respiratory health, ability to equalise pressure and the intended treatment goal.

Treatment should take place in an appropriate medical-grade hyperbaric chamber with trained clinical supervision and established oxygen and fire-safety procedures. ^{19 20}

Frequently Asked Questions

Can HBOT reverse ageing?

HBOT should not be described as a guaranteed method of reversing ageing.

Research suggests that it can influence several biological mechanisms associated with ageing, including vascular function, inflammation, mitochondrial activity, cellular senescence and telomere dynamics. However, favourable biomarker changes do not prove that the entire ageing process has been reversed.

Is HBOT a replacement for exercise, nutrition or sleep?

No. Exercise, good nutrition and restorative sleep remain fundamental to long-term physical, cognitive and metabolic health. HBOT may support some of the same physiological systems, but it should complement these foundations rather than replace them.

Can HBOT improve sleep?

Emerging evidence suggests that HBOT may improve patient-reported sleep quality, sleep latency, sleep disturbances and daytime functioning in selected populations. The greatest improvements have been reported in people with poor sleep before treatment. The evidence is still developing, and HBOT is not a substitute for investigating and treating the underlying cause of a sleep problem. ^{9 10}

How many HBOT sessions are usually required?

The number varies according to the individual’s health, treatment goal and clinical response. Studies discussed in this article used approximately 10 to 60 sessions or exposures. The course should be prescribed by a physician trained in hyperbaric medicine rather than selected as a standard wellness package.

Is one HBOT session enough?

A single session can produce immediate physiological changes, including increased tissue oxygenation. Many of the angiogenic, mitochondrial, regenerative and neuroplastic effects discussed in research have been studied after repeated treatment. One session should not be expected to reproduce outcomes reported after a structured course.

Is HBOT safe for everyone?

No medical treatment is appropriate for everyone. A physician should review medical history, current conditions, medications and potential contraindications before HBOT begins. Treatment should then be delivered under appropriate clinical supervision.

Can HBOT replace standard medical or surgical treatment?

No. HBOT may be a valuable adjunct in selected situations, but it must not be used to delay necessary diagnosis, medication, surgery, rehabilitation or specialist treatment.

Research Summary

1. Hyperbaric oxygen therapy may support regenerative processes and healthy ageing through effects on angiogenesis, inflammation, antioxidant defence, mitochondrial function, stem-cell mobilisation and cellular senescence. Clinical research has reported potential improvements in cognition, cardiorespiratory performance, metabolic function, skin health and sleep quality.
2. Ageing is complex and multifaceted. HBOT should be integrated into a comprehensive approach that includes a healthy diet, regular exercise, restorative sleep, stress management, emotional and mental wellbeing, preventive medical care and treatment of existing health conditions.
3. HBOT is generally safe and well tolerated when properly administered, but it is not appropriate for everyone. Physician assessment is required before treatment.
4. The treatment strategy depends on the individual’s goals and medical background. Courses may range from approximately 10 to 60 sessions, but the number, pressure, duration and frequency should be determined by a medical doctor trained in hyperbaric oxygen medicine.
5. HBOT is a medical tool and adjunct. It is not a replacement for standard medical or surgical care, rehabilitation or the foundations of health.

References